TrialToxins2020

Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.

Masahiro Abo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.